Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 22
Page 279
... prednisolone . This drug is a 1 : 1 mixture of two epimers designated 22R and 22S , with the 22R epimer about three times more potent than the 22S epimer1 . Budesonide has high topical anti - inflammatory activity with about a 100 ...
... prednisolone . This drug is a 1 : 1 mixture of two epimers designated 22R and 22S , with the 22R epimer about three times more potent than the 22S epimer1 . Budesonide has high topical anti - inflammatory activity with about a 100 ...
Page 281
... prednisolone 40 mg daily , tapered to 5 mg daily . Budesonide did not influence cortisol levels , whereas levels were suppressed in the group receiving prednisolone . However , budesonide showed a lesser efficacy in the healing of the ...
... prednisolone 40 mg daily , tapered to 5 mg daily . Budesonide did not influence cortisol levels , whereas levels were suppressed in the group receiving prednisolone . However , budesonide showed a lesser efficacy in the healing of the ...
Page 286
... prednisolone enema as positive control . Scand J Gastroenterol . 1991 ; 26 : 1225-30 . 17. Lofberg R , Ostergaard - Thomsen O , Langholtz et al . Budesonide versus prednisolone retention enemas in active distal ulcerative colitis ...
... prednisolone enema as positive control . Scand J Gastroenterol . 1991 ; 26 : 1225-30 . 17. Lofberg R , Ostergaard - Thomsen O , Langholtz et al . Budesonide versus prednisolone retention enemas in active distal ulcerative colitis ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis